Biosergen AB (FRA:8N10) Accounts Payable: €0.00 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:8N10 Biosergen AB FRA:8N10
24 GF Score
Price €0.05
View Full Analysis

What is Biosergen AB Accounts Payable?

Biosergen AB FRA:8N10 -53.06% 24 Accounts Payable is €0.00 Mil as of Dec. 2025. GuruFocus rates FRA:8N10 with a GF Score™ of 24/100.

Biosergen AB's Accounts Payable for the quarter that ended in Dec. 2025 was €0.00 Mil.

Biosergen AB's quarterly Accounts Payable declined from Dec. 2024 (€0.21 Mil) to Jun. 2025 (€0.00 Mil) but then stayed the same from Jun. 2025 (€0.00 Mil) to Dec. 2025 (€0.00 Mil).

Biosergen AB's annual Accounts Payable increased from Dec. 2023 (€0.15 Mil) to Dec. 2024 (€0.21 Mil) and increased from Dec. 2024 (€0.21 Mil) to Dec. 2025 (€0.50 Mil).

Biosergen AB Accounts Payable Historical Data

* Premium members only.

The historical data trend for Biosergen AB's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biosergen AB Accounts Payable Chart

Biosergen AB Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial 0.66 0.61 0.15 0.21 0.50

Biosergen AB Quarterly Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.21 0.00 0.00
FRA:8N10
24GF Score
Biosergen AB FRA:8N10
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biosergen AB Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of €0.00 Mil mean?
Biosergen AB (FRA:8N10) has a Accounts Payable of €0.00 Mil as of Dec. 2025. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Biosergen AB and its competitors.
Is Biosergen AB's Accounts Payable too high?
Biosergen AB's current Accounts Payable is €0.00 Mil. Overall, Biosergen AB has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Biosergen AB's Accounts Payable compare to VRTX and REGN?
Biosergen AB's Accounts Payable of €0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Biosergen AB and its competitors. Biosergen AB's current Accounts Payable is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biosergen AB stock overvalued right now?
Biosergen AB (FRA:8N10) has a current Accounts Payable of €0.00 Mil. The current Accounts Payable is €0.00 Mil. Biosergen AB's overall GF Score™ is 24/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Biosergen AB (FRA:8N10), the current Accounts Payable is €0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biosergen AB Business Description

Other Exchanges BIOSGN:Sweden
Address Fogdevreten 2, Solna, SWE, 17165
Biosergen AB is a clinical stage biotechnology company advancing the treatment of life-threatening fungal infections. Biosergen' s mission is to develop the drug candidate BSG005 into a superior antifungal therapy with broader efficacy and improved safety over existing treatments. BSG005 potential is to eliminate fungal infections rather than just slowing their growth, reducing the risk of resistance.
24GF Score

Get the complete analysis for FRA:8N10

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.05
Price